Skip to content

CPHARM - CRC Study

Community Pharmacy-Based Health-Seeking Behaviour and Colorectal Cancer Screening Uptake Among Malaysian Adults

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07714291
Enrollment
316
Registered
2026-07-20
Start date
2026-11-01
Completion date
2027-01-01
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.

Interventions

BEHAVIORALHealth awareness campaign

Campaign Components The one-day Ribbon of Hope campaign will be implemented at each intervention pharmacy to promote colorectal cancer awareness and screening uptake. The campaign consists of educational materials and one-on-one education about colorectal cancer.

Sponsors

Monash University Malaysia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 50 to 75 years * Visiting participating community pharmacies during the study period * Able to provide informed consent * Willing to complete the study questionnaire * Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results

Exclusion criteria

* Previous diagnosis of colorectal cancer * History of colonoscopy within the recommended screening interval (within past 1 year) * Currently experiencing symptoms suggestive of colorectal cancer * Having a first-degree relative diagnosed with colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Beliefs and perceptions toward colorectal cancer and iFOBT screeningFrom enrollment to the 8th week follow-up.Beliefs and perceptions toward colorectal cancer and iFOBT screening, measured using the Champion Health Belief Model Scale - Colorectal Cancer - Malay (CHBMS-CRC-M) subscales of perceived susceptibility, perceived benefits, and perceived barriers, between customers from pharmacies with and without the one-day awareness campaign. Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores will be calculated by summing (or averaging) the items within each domain, with higher scores indicating greater perceived susceptibility, benefits or barriers.

Secondary

MeasureTime frame
Proportion of participants who were willing to accept and perform iFOBT, report iFOBT results, and follow-up if needed.From enrollment to the 8th week of follow-up

Countries

Malaysia

Contacts

CONTACTYen Jun Wong
yenjun.wong@monash.edu60355146286
CONTACTChee Tao Chang
davidcct.crc@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026